FDA Acknowledgments

ZandCell is an American company that produces COVID-19 Dual Antibody Serology Tests. ZandCell’s COVID-19 Dual Antibody Tests have been assigned with an FDA Emergency Use Authorization number on April 5, 2020. The FDA does not object to the use of this test.

On March 16, 2020, the FDA issued guidelines stating they do not intend to object to COVID-19 Dual Antibody Serology tests, as long as the FDA guidelines are followed.

Our tests are manufactured following all FDA guidelines in FDA compliant facilities. These tests are for professional diagnostic use to be administered under the supervision of a health care professional.

EASTCANN PTE. LTD., SMARTCHEK and COVID AP are exclusive authorized distributors for ZandCell COVID-19 Rapid Test in North America.

SmartChek a subsidiary of Mullen Technologies Inc.